Healthlead Public Company Limited(TH:HL)
฿4.50+0.00 (+0.90%)
TH:HL
Healthlead Public Company Limited financials statements
฿4.50
At close:+0.00 (+0.90%)
Healthlead Public Company Limited (HL) Ratios
Healthlead Public Company Limited Ratios
TH:HL's free cash flow for Q2 2026 was ฿-33.38M. For the 2026 fiscal year, TH:HL's free cash flow was decreased by ฿-9.08M and operating cash flow was ฿-24.30M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 3.40 | 4.05 | 4.26 | 4.76 | 6.14 |
| Quick Ratio | 2.24 | 2.67 | 3.09 | 3.63 | 5.04 |
| Cash Ratio | 0.14 | 0.80 | 1.68 | 0.78 | 4.88 |
| Solvency Ratio | 0.27 | 0.31 | 0.32 | 0.45 | 0.44 |
| Operating Cash Flow Ratio | 0.74 | 0.42 | 0.46 | 0.73 | 0.59 |
| Short-Term Operating Cash Flow Coverage | 0.00 | 0.00 | 0.00 | 0.00 | 21.65 |
| Net Current Asset Value | ฿ 282.57M | ฿ 361.09M | ฿ 433.66M | ฿ 544.15M | ฿ 634.55M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.20 | 0.20 | 0.16 | 0.13 | 0.11 |
| Debt-to-Equity Ratio | 0.33 | 0.29 | 0.23 | 0.18 | 0.14 |
| Debt-to-Capital Ratio | 0.25 | 0.23 | 0.19 | 0.15 | 0.12 |
| Long-Term Debt-to-Capital Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Financial Leverage Ratio | 1.65 | 1.49 | 1.43 | 1.37 | 1.29 |
| Debt Service Coverage Ratio | 8.05 | 12.41 | 15.55 | 28.30 | 12.50 |
| Interest Coverage Ratio | 3.71 | 7.48 | 11.21 | 25.92 | 19.24 |
| Debt to Market Cap | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Debt Per Share | 1.25 | 1.14 | 0.86 | 0.64 | 0.60 |
| Net Debt to EBITDA | 1.82 | 0.68 | -0.69 | 0.11 | -4.39 |
| Profitability Margins | |||||
| Gross Profit Margin | 22.50% | 23.51% | 23.06% | 24.76% | 23.05% |
| EBIT Margin | 2.76% | 5.57% | 6.30% | 9.77% | 8.56% |
| EBITDA Margin | 6.92% | 9.47% | 9.72% | 12.28% | 11.14% |
| Operating Profit Margin | 2.76% | 5.15% | 6.16% | 9.77% | 8.57% |
| Pretax Profit Margin | 4.42% | 4.88% | 5.75% | 9.40% | 8.12% |
| Net Profit Margin | 3.49% | 3.96% | 4.57% | 7.78% | 6.65% |
| Continuous Operations Profit Margin | 3.49% | 3.96% | 4.57% | 7.78% | 6.65% |
| Net Income Per EBT | 79.05% | 81.14% | 79.42% | 82.77% | 81.84% |
| EBT Per EBIT | 159.97% | 94.72% | 93.36% | 96.25% | 94.80% |
| Return on Assets (ROA) | 4.87% | 5.22% | 5.40% | 9.18% | 7.12% |
| Return on Equity (ROE) | 8.05% | 7.78% | 7.71% | 12.55% | 9.20% |
| Return on Capital Employed (ROCE) | 4.63% | 7.91% | 8.51% | 13.48% | 10.54% |
| Return on Invested Capital (ROIC) | 3.54% | 6.24% | 6.62% | 10.96% | 8.49% |
| Return on Tangible Assets | 4.95% | 5.31% | 5.50% | 9.35% | 7.28% |
| Earnings Yield | 4.03% | 2.82% | 2.57% | 1.77% | 2.13% |
| Efficiency Ratios | |||||
| Receivables Turnover | 45.03 | 45.58 | 44.21 | 62.45 | 51.72 |
| Payables Turnover | 9.38 | 11.03 | 9.22 | 8.67 | 8.58 |
| Inventory Turnover | 5.57 | 5.20 | 5.43 | 5.44 | 5.79 |
| Fixed Asset Turnover | 4.04 | 3.60 | 3.62 | 4.50 | 6.26 |
| Asset Turnover | 1.39 | 1.32 | 1.18 | 1.18 | 1.07 |
| Working Capital Turnover Ratio | 3.46 | 3.06 | 2.42 | 2.10 | 3.15 |
| Cash Conversion Cycle | 34.68 | 45.07 | 35.88 | 30.90 | 27.54 |
| Days of Sales Outstanding | 8.11 | 8.01 | 8.26 | 5.84 | 7.06 |
| Days of Inventory Outstanding | 65.49 | 70.15 | 67.20 | 67.13 | 63.00 |
| Days of Payables Outstanding | 38.92 | 33.09 | 39.58 | 42.08 | 42.52 |
| Operating Cycle | 73.59 | 78.16 | 75.46 | 72.98 | 70.06 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | 0.74 | 0.33 | 0.34 | 0.50 | 0.41 |
| Free Cash Flow Per Share | 0.62 | 0.04 | 0.03 | 0.06 | 0.34 |
| Dividend Paid and CapEx Coverage Ratio | 2.54 | 0.74 | 0.69 | 0.83 | 1.61 |
| Capital Expenditure Coverage Ratio | 6.18 | 1.13 | 1.10 | 1.13 | 5.75 |
| Operating Cash Flow Coverage Ratio | 0.62 | 0.30 | 0.41 | 0.81 | 0.72 |
| Operating Cash Flow to Sales Ratio | 0.09 | 0.04 | 0.06 | 0.09 | 0.07 |
| Free Cash Flow Yield | 8.62% | 0.37% | 0.29% | 0.23% | 1.88% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | 24.83 | 35.17 | 39.63 | 57.21 | 46.41 |
| Price-to-Sales (P/S) Ratio | 0.87 | 1.40 | 1.78 | 4.40 | 3.12 |
| Price-to-Book (P/B) Ratio | 2.00 | 2.76 | 3.01 | 7.10 | 4.31 |
| Price-to-Free Cash Flow (P/FCF) Ratio | 11.60 | 269.83 | 346.90 | 430.77 | 53.06 |
| Price-to-Operating Cash Flow Ratio | 9.72 | 31.26 | 31.89 | 49.13 | 43.84 |
| Price-to-Earnings Growth (PEG) Ratio | 0.00 | 4.75 | -1.07 | 5.58 | 0.44 |
| Enterprise Value Multiple | 14.35 | 15.51 | 17.60 | 35.96 | 23.56 |
| Enterprise Value | 2.21B | 2.90B | 2.80B | 6.71B | 3.15B |
| EV to EBITDA | 14.35 | 15.51 | 17.60 | 35.96 | 23.56 |
| EV to Sales | 0.99 | 1.47 | 1.71 | 4.42 | 2.63 |
| EV to Free Cash Flow | 13.29 | 282.26 | 333.72 | 432.12 | 44.72 |
| EV to Operating Cash Flow | 11.14 | 32.70 | 30.68 | 49.28 | 36.95 |
| Tangible Book Value Per Share | 3.51 | 3.60 | 3.47 | 3.38 | 4.08 |
| Shareholders’ Equity Per Share | 3.60 | 3.70 | 3.56 | 3.46 | 4.20 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.21 | 0.19 | 0.21 | 0.17 | 0.18 |
| Revenue Per Share | 8.30 | 7.27 | 6.01 | 5.59 | 5.81 |
| Net Income Per Share | 0.29 | 0.29 | 0.27 | 0.43 | 0.39 |
| Tax Burden | 0.79 | 0.81 | 0.79 | 0.83 | 0.82 |
| Interest Burden | 1.60 | 0.88 | 0.91 | 0.96 | 0.95 |
| Research & Development to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A to Revenue | 0.22 | 0.21 | 0.19 | 0.16 | 0.16 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Quality | 2.55 | 1.13 | 1.22 | 1.15 | 1.07 |
Currency in THB
